Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 13 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Quick Heal Technologies Ltd

Basic Stock Data

Last Updated: June 12, 2024, 10:26 pm

Market Cap 2,334 Cr.
Current Price 436
High / Low600/148
Stock P/E96.3
Book Value 81.7
Dividend Yield0.56 %
ROCE6.15 %
ROE5.66 %
Face Value 10.0
PEG Ratio-5.62

Competitors of Quick Heal Technologies Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Alphalogic Techsys Ltd 1,442 Cr. 308401/32.6348 8.480.00 %17.1 %12.3 % 5.00
Aurionpro Solutions Ltd 7,023 Cr. 2,5442,800/88049.8 3620.10 %22.3 %19.8 % 10.0
Wipro Ltd 2,51,212 Cr. 480546/37522.7 1430.21 %17.2 %14.5 % 2.00
Tera Software Ltd 92.2 Cr. 73.782.5/39.621.9 89.90.00 %%% 10.0
Blue Cloud Softech Solutions Ltd 2,856 Cr. 131131/46.1498 3.030.00 %20.2 %14.6 % 2.00
Industry Average52,525.04 Cr707.34188.08121.280.06%15.36%12.24%5.80

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales105551048010461101674951788280
Expenses52505759696073786567677070
Operating Profit545462035128-11-16-15111210
OPM %51%9%45%26%34%2%28%-17%-33%-29%14%14%13%
Other Income66446353105647
Interest0000000000000
Depreciation5445544443333
Profit before tax547462036030-12-10-13131314
Tax %27%16%24%27%22%40%25%23%33%4%4%20%-4%
Net Profit406351428022-9-7-13131014
EPS in Rs6.181.075.982.464.840.033.82-1.75-1.25-2.402.431.892.62

Last Updated: June 9, 2024, 12:16 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 27, 2024, 5:59 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales205243286302300318315286333342278292
Expenses101157194200210198187195192235276274
Operating Profit10485921029012012892141107218
OPM %51%35%32%34%30%38%41%32%42%31%1%6%
Other Income11118102530333124192221
Interest000000000000
Depreciation41120243127242219171613
Profit before tax11086808884123137101146109826
Tax %30%32%33%34%37%33%33%27%27%23%20%8%
Net Profit775854585383927410783624
EPS in Rs100.749.568.818.277.5911.7913.0111.5916.6614.341.214.53
Dividend Payout %2%78%85%30%33%25%15%35%24%31%207%66%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-24.68%-6.90%7.41%-8.62%56.60%10.84%-19.57%44.59%-22.43%-92.77%300.00%
Change in YoY Net Profit Growth (%)0.00%17.78%14.30%-16.03%65.22%-45.76%-30.41%64.16%-67.02%-70.34%392.77%

Growth

Compounded Sales Growth
10 Years:2%
5 Years:-2%
3 Years:-4%
TTM:5%
Compounded Profit Growth
10 Years:-8%
5 Years:-23%
3 Years:-39%
TTM:2856%
Stock Price CAGR
10 Years:%
5 Years:20%
3 Years:21%
1 Year:163%
Return on Equity
10 Years:10%
5 Years:9%
3 Years:6%
Last Year:6%

Last Updated: June 7, 2024, 9:22 am

Quick Heal Technologies Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital886161707070716464585353
Reserves203277271270559592653719580687570367343
Borrowings0000000000000
Other Liabilities19294797887257635275887466
Total Liabilities230314380428717734781853697827716493462
Fixed Assets193882111142185173165158146137124122
CWIP242955745514141132000
Investments100139131130115182306390310416318198172
Other Assets87107111113405353287288225263261171167
Total Assets230314380428717734781853697827716493462

Reserves and Borrowings Chart

Quick Heal Technologies Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 496861777836946171998031
Cash from Investing Activity -53-63-59-53-163-73-122-37148-92126185
Cash from Financing Activity 0-1-2-18189-20-19-24-2210-214-212
Net Cash Flow-44-17104-57-471-36-94

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow104.0085.0092.00102.0090.00120.00128.0092.00141.00107.002.0018.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Quick Heal Technologies Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days13413810483112118118145144165184161
Inventory Days181144
Days Payable8641,103
Cash Conversion Cycle134138104-600-847118118145144165184161
Working Capital Days10510352-2329497092949810283
ROCE %44%27%24%18%14%18%18%14%21%15%0%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters73.02%72.99%72.92%72.86%72.84%72.78%73.08%73.08%73.08%73.06%72.76%72.48%
FIIs0.52%0.97%1.57%1.77%1.74%1.76%2.17%2.04%2.02%1.56%1.66%1.65%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.13%1.44%2.06%
Public26.47%26.04%25.51%25.37%25.42%25.45%24.76%24.89%24.91%24.23%24.13%23.81%
No. of Shareholders63,17369,62166,99267,49166,76975,04466,02865,11963,44557,52850,24946,923

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)4.561.1414.0116.6611.34
Diluted EPS (Rs.)4.481.1413.9416.6511.34
Cash EPS (Rs.)6.884.2217.3419.7014.97
Book Value[Excl.RevalReserv]/Share (Rs.)81.6779.09108.19117.04100.32
Book Value[Incl.RevalReserv]/Share (Rs.)81.6779.09108.19117.04100.32
Revenue From Operations / Share (Rs.)54.5252.4058.9451.8744.57
PBDIT / Share (Rs.)7.284.5221.7325.8019.16
PBIT / Share (Rs.)4.921.5118.7322.7615.78
PBT / Share (Rs.)4.901.5118.7322.7615.78
Net Profit / Share (Rs.)4.531.2114.3416.6611.59
NP After MI And SOA / Share (Rs.)4.531.2114.3416.6611.59
PBDIT Margin (%)13.348.6336.8749.7342.98
PBIT Margin (%)9.022.8831.7843.8735.40
PBT Margin (%)8.982.8831.7843.8735.40
Net Profit Margin (%)8.302.3024.3332.1226.00
NP After MI And SOA Margin (%)8.302.3024.3332.1226.00
Return on Networth / Equity (%)5.541.5213.2514.2311.55
Return on Capital Employeed (%)5.991.9017.2519.4115.67
Return On Assets (%)4.721.2911.6212.9410.68
Asset Turnover Ratio (%)0.580.460.440.430.36
Current Ratio (X)4.964.506.208.539.56
Quick Ratio (X)4.934.436.158.499.43
Inventory Turnover Ratio (X)0.110.230.240.210.14
Dividend Payout Ratio (NP) (%)0.00407.9627.850.0051.76
Dividend Payout Ratio (CP) (%)0.00116.6123.030.0040.08
Earning Retention Ratio (%)0.00-307.9672.150.0048.24
Cash Earning Retention Ratio (%)0.00-16.6176.970.0059.92
Interest Coverage Ratio (X)299.540.000.000.000.00
Interest Coverage Ratio (Post Tax) (X)187.460.000.000.000.00
Enterprise Value (Cr.)2480.96695.04966.921113.79441.62
EV / Net Operating Revenue (X)8.502.502.833.341.54
EV / EBITDA (X)63.7128.957.676.723.59
MarketCap / Net Operating Revenue (X)8.632.543.013.601.82
Retention Ratios (%)0.00-307.9672.140.0048.23
Price / BV (X)5.761.681.641.590.80
Price / Net Operating Revenue (X)8.632.543.013.601.82
EarningsYield0.010.010.080.080.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 447.81

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 2.71% compared to the current price 436

Intrinsic Value: 371.10

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Overvalued: 14.88% compared to the current price ₹436

Last 5 Year EPS CAGR: -17.13%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 17.75%, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -3.00, which is a positive sign.
  3. The company has higher reserves (494.00 cr) compared to borrowings (0.00 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (291.67 cr) and profit (91.50 cr) over the years.
  1. The stock has a high average Working Capital Days of 71.17, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Quick Heal Technologies Ltd:
    1. Net Profit Margin: 8.30%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 5.99% (Industry Average ROCE: 15.36%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 5.54% (Industry Average ROE: 12.24%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 187.46
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 4.93
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 96.3 (Industry average Stock P/E: 188.08)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. ✗ Total Debt / Equity: N/A
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company

Quick Heal Technologies Ltd. is a Public Limited Listed company incorporated on 07/08/1995 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L72200MH1995PLC091408 and registration number is 091408. Currently Company is involved in the business activities of Research and experimental development on social sciences and humanities. Company’s Total Operating Revenue is Rs. 341.55 Cr. and Equity Capital is Rs. 58.01 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
IT Consulting & SoftwareMarvel Edge, Office No. 7010 C & D, Pune Maharashtra 411014cs@quickheal.co.in
http://www.quickheal.co.in
Management
NamePosition Held
Dr. Kailash Sahebrao KatkarManaging Director & CEO
Dr. Sanjay Sahebrao KatkarJoint Managing Director & CTO
Mr. Shailesh LakhaniNon Executive Director
Mr. Richard StiennonIndependent Director
Ms. Apurva Pradeep JoshiIndependent Director
Mr. Amitabha MukhopadhyayIndependent Director
Air M'shal (Retd.) Bhushan Nilkanth GokhaleIndependent Director

FAQ

What is the latest fair value of Quick Heal Technologies Ltd?

The latest fair value of Quick Heal Technologies Ltd is ₹447.81.

What is the Market Cap of Quick Heal Technologies Ltd?

The Market Cap of Quick Heal Technologies Ltd is 2,334 Cr..

What is the current Stock Price of Quick Heal Technologies Ltd as on 13 June 2024?

The current stock price of Quick Heal Technologies Ltd as on 13 June 2024 is ₹436.

What is the High / Low of Quick Heal Technologies Ltd stocks in FY 2024?

In FY 2024, the High / Low of Quick Heal Technologies Ltd stocks is 600/148.

What is the Stock P/E of Quick Heal Technologies Ltd?

The Stock P/E of Quick Heal Technologies Ltd is 96.3.

What is the Book Value of Quick Heal Technologies Ltd?

The Book Value of Quick Heal Technologies Ltd is 81.7.

What is the Dividend Yield of Quick Heal Technologies Ltd?

The Dividend Yield of Quick Heal Technologies Ltd is 0.56 %.

What is the ROCE of Quick Heal Technologies Ltd?

The ROCE of Quick Heal Technologies Ltd is 6.15 %.

What is the ROE of Quick Heal Technologies Ltd?

The ROE of Quick Heal Technologies Ltd is 5.66 %.

What is the Face Value of Quick Heal Technologies Ltd?

The Face Value of Quick Heal Technologies Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Quick Heal Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE